CONSOLE, LARA
 Distribuzione geografica
Continente #
NA - Nord America 3.139
AS - Asia 2.497
EU - Europa 1.568
SA - Sud America 619
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 148
OC - Oceania 6
Totale 8.172
Nazione #
US - Stati Uniti d'America 2.977
SG - Singapore 956
IT - Italia 594
CN - Cina 452
BR - Brasile 407
VN - Vietnam 367
DE - Germania 250
UA - Ucraina 206
HK - Hong Kong 180
BD - Bangladesh 158
FR - Francia 117
SN - Senegal 93
AR - Argentina 75
FI - Finlandia 72
IN - India 72
SE - Svezia 72
CA - Canada 69
AT - Austria 63
MX - Messico 46
KR - Corea 41
GB - Regno Unito 39
TR - Turchia 39
IQ - Iraq 32
CO - Colombia 30
ID - Indonesia 29
PK - Pakistan 29
RU - Federazione Russa 28
EC - Ecuador 26
ZA - Sudafrica 22
MA - Marocco 20
CL - Cile 19
NL - Olanda 19
VE - Venezuela 19
ES - Italia 18
JP - Giappone 17
SA - Arabia Saudita 16
PE - Perù 15
PL - Polonia 15
TN - Tunisia 15
MY - Malesia 14
BO - Bolivia 12
PH - Filippine 12
UZ - Uzbekistan 12
RO - Romania 9
UY - Uruguay 9
BE - Belgio 8
CZ - Repubblica Ceca 8
EG - Egitto 8
DZ - Algeria 7
IE - Irlanda 7
JM - Giamaica 7
KE - Kenya 7
NP - Nepal 7
PY - Paraguay 7
CR - Costa Rica 6
ET - Etiopia 6
HN - Honduras 6
JO - Giordania 6
KZ - Kazakistan 6
NI - Nicaragua 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
HU - Ungheria 5
IL - Israele 5
LB - Libano 5
NG - Nigeria 5
OM - Oman 4
PS - Palestinian Territory 4
TH - Thailandia 4
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
MD - Moldavia 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
EU - Europa 2
GD - Grenada 2
GP - Guadalupe 2
GT - Guatemala 2
HR - Croazia 2
IR - Iran 2
LT - Lituania 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
Totale 8.003
Città #
Singapore 431
San Jose 311
Chandler 267
Ashburn 264
Council Bluffs 253
Hong Kong 176
Ho Chi Minh City 137
Dallas 129
Beijing 113
Boardman 112
Jacksonville 108
San Mateo 99
Milan 96
Dakar 93
Santa Clara 91
New York 80
Hanoi 71
Munich 68
Lauterbourg 58
Los Angeles 55
Dearborn 54
Helsinki 51
Shanghai 50
Vienna 49
Rome 45
Rende 42
Cosenza 41
Lawrence 41
Roxbury 41
Seoul 40
São Paulo 35
Inglewood 34
Bremen 32
Des Moines 29
Florence 28
Frankfurt am Main 28
Hefei 28
Columbus 27
The Dalles 27
Ottawa 24
Brooklyn 22
Chicago 21
Izmir 21
Secaucus 21
Naples 19
Pune 19
Da Nang 18
Haiphong 18
Rio de Janeiro 18
Guangzhou 16
London 16
Orem 16
Turku 16
Miano 15
Ogden 15
Bologna 14
Buffalo 14
Falkenstein 14
Seattle 14
Baghdad 13
Mexico City 13
Wilmington 13
Biên Hòa 12
Mumbai 12
North Bergen 12
Phoenix 12
San Francisco 12
Tokyo 12
Bari 11
Jakarta 11
Johannesburg 11
Lima 11
Boston 10
Brasília 10
Charlotte 10
Figino 10
Kuala Lumpur 10
Paris 10
Warsaw 10
Buenos Aires 9
Dhaka 9
Karachi 9
Tashkent 9
Toronto 9
Wuxi 9
Amsterdam 8
Atlanta 8
Brussels 8
Lahore 8
Marano Marchesato 8
Redwood City 8
Reggio Calabria 8
Ann Arbor 7
Casablanca 7
Catania 7
Genoa 7
Guarulhos 7
Guayaquil 7
Philadelphia 7
Tunis 7
Totale 4.476
Nome #
Studying interactions of drugs with cell membrane nutrient transporters: New frontiers of proteoliposome nanotechnology 279
The Human SLC1A5 (ASCT2) amino acid transporter: From function to structure and role in cell biology 238
Cys site-directed mutagenesis of the human SLC1A5 (ASCT2) transporter: Structure/function relationships and crucial role of Cys467 for redox sensing and glutamine transport 233
Carnitine Traffic in Cells. Link With Cancer 201
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter 199
Glutamine transport and mitochondrial metabolism in cancer cell growth 192
Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs 191
Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology 182
Chemical Targeting of Membrane Transporters: Insights into Structure/Function Relationships 178
Mitochondrial Carnitine/Acylcarnitine Transporter, a Novel Target of Mercury Toxicity 173
Cysteine 467 of the ASCT2 Amino Acid Transporter Is a Molecular Determinant of the Antiport Mechanism 169
Carnitine traffic and human fertility 167
ASCT1 and ASCT2: Brother and Sister? 165
The human SLC7A5 (LAT1): The intriguing histidine/large neutral amino acid transporter and its relevance to human health 164
Chemical approaches for studying the biology and pharmacology of membrane transporters: The histidine/large amino acid transporter slc7a5 as a benchmark 163
Exosomes in inflammation and role as biomarkers 156
Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships 154
Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane (vol 394, pg 307, 2014) 152
Inhibition of the carnitine acylcarnitine carrier by carbon monoxide reveals a novel mechanism of action with non-metal-containing proteins 151
Tryptophan 224 of the rat mitochondrial carnitine/acylcarnitine carrier is crucial for the antiport mechanism 144
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 137
Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane 136
Mitochondrial Carnitine/Acylcarnitine Translocase: Insights in Structure/Function Relationships. Basis for Drug Therapy and Side Effects Prediction 133
Glutamine transporters as pharmacological targets: From function to drug design 133
Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring 132
N-linked Glycosylation of human SLC1A5 (ASCT2) transporter is critical for trafficking to membrane 130
Bacterial over-production of the functionally active human SLC38A2 (SNAT2) exploiting the mistic tag: a cheap and fast tool for testing ligands 129
Structure/function relationships of the human mitochondrial ornithine/citrulline carrier by Cys site-directed mutagenesis. Relevance to mercury toxicity 128
Functional Study of the Human Riboflavin Transporter 2 Using Proteoliposomes System 128
OCTN: A Small Transporter Subfamily with Great Relevance to Human Pathophysiology, Drug Discovery, and Diagnostics 127
Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2) 127
Overproduction, Purification, and Stability of the Functionally Active Human Carnitine Acetyl Transferase 125
Impact of natural mutations on the riboflavin transporter 2 and their relevance to human riboflavin transporter deficiency 2 125
OCTN1 (SLC22A4) displays two different transport pathways for organic cations or zwitterions 122
Identification of Amino Acid Residues Underlying the Antiport Mechanism of the Mitochondrial Carnitine/Acylcarnitine Carrier by Site-Directed Mutagenesis and Chemical Labeling 121
Post-translational modification by acetylation regulates the mitochondrial carnitine/acylcarnitine transport protein 121
Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203 120
N-glycosylation is crucial for trafficking and stability of SLC3A2 (CD98) 120
OCTN1 (SLC22A4) as a Target of Heavy Metals: Its Possible Role in Microplastic Threats 119
OCTN1: A Widely Studied but Still Enigmatic Organic Cation Transporter Linked to Human Pathology and Drug Interactions 119
Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance 114
The yeast P-pastoris as a tool for large scale production of WT and mutant human amino acid transporter SLC1A5 111
The mitochondrial carnitine/acylcarnitine carrier is regulated by hydrogen sulfide via interaction with C136 and C155 111
Corrigendum to “The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)” [Biochem. Pharmacol. 194 (2021) 114840](S0006295221004561)(10.1016/j.bcp.2021.114840) 109
The mitochondrial carnitine acyl-carnitine carrier (Slc25a20): Molecular mechanisms of transport, role in redox sensing and interaction with drugs 109
Structure-based virtual screening to identify novel carnitine acetyltransferase activators 104
Strategies for Successful Over-Expression of Human Membrane Transport Systems Using Bacterial Hosts: Future Perspectives 101
Inhibition of the Mitochondrial Carnitine/Acylcarnitine Carrier by Itaconate through Irreversible Binding to Cysteine 136: Possible Pathophysiological Implications 98
Reconstitution in proteoliposomes of the recombinant human riboflavin transporter 2 (SLC52A2) overexpressed in E. coli 97
LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism 94
The Link Between the Mitochondrial Fatty Acid Oxidation Derangement and Kidney Injury 91
Lysine 204 is crucial for the antiport function of the human LAT1 transporter 89
Human mitochondrial carnitine acylcarnitine carrier: Molecular target of dietary bioactive polyphenols from sweet cherry (Prunus avium L.) 89
Effect of 7-ketocholesterol incorporation on substrate binding affinity and turnover rate of the organic cation transporter 2 (OCT2) 87
An innovative small molecule for promoting neuroreparative strategies 85
The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2) 74
Nitric oxide inhibits the mitochondrial carnitine/acylcarnitine carrier through reversible S-nitrosylation of cysteine 136. 72
Inflammation and Organic Cation Transporters Novel (OCTNs) 69
Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier 43
Production of the recombinant human riboflavin transporters SLC52A1, 3 and functional assay in proteoliposomes 42
Impact of 7-ketocholesterol on the function and stability of the LAT1 transporter 39
The antiport mechanism of the human LAT1 transporter: defining the molecular determinants by means of wet and dry approaches 35
Altered dimerization of certain riboflavin transporter 2 mutants: a possible source of UPR, altered calcium signalling and mitochondrial derangements in RTD2 35
Cholesterol, but not its oxidized derivatives, is essential for the transport activity of ASC1 (SLC7A10) 29
Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction? 25
Structure/function relationships of mitochondrial protein carrier (SLC25A20) for carnitine/acylcarnitine: A review 9
The heterodimeric amino acid transporters (HAT) of the SLC7/SLC3 family: A structure-function relationships and relevance to human pathology 8
The APOL1 variant p.N264K is predicted to block ion flow by occluding a pore at the cell surface 7
Therapeutic potential of mitochonic acid (MA-5) in modulating mitochondrial function and inflammatory responses: A focus on carnitine/acylcarnitine carrier (SLC25A20) transport activity 7
Characterization of the lysosomal arginine transporter SLC7A14 6
Totale 8.172
Categoria #
all - tutte 43.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022449 0 0 0 29 57 12 2 114 9 5 87 134
2022/2023717 77 99 19 87 89 67 12 95 65 23 48 36
2023/2024453 37 33 26 21 36 74 27 31 26 28 33 81
2024/20251.224 62 132 33 72 77 107 76 82 128 76 127 252
2025/20263.545 362 139 297 224 555 340 413 184 349 242 259 181
2026/20271.152 279 218 258 397 0 0 0 0 0 0 0 0
Totale 8.172